Snowball logo
logo
LDXH

Lumos Diagnostics Holdings Limited

LDXHF • PINK
$0.0585$0.00  (0%)
Estimate
EPS
-0.01
Beta
0.462
Growth
Revenue, YoY
12.15%
Net income, YoY
98.65%
FCF, YoY
82.19%
About the company
Ticker
LDXHF
ISIN
Country
Australia
Sector (GICS)
Healthcare
Lumos Diagnostics Holdings Limited develops, manufactures, and distributes diagnostic technologies in the United States. The company offers FebriDx, a point-of-care diagnostic test for acute respiratory infections, and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms. The company was incorporated in 2018 and is headquartered in Carlsbad, California.

Frequently asked questions

What sector does Lumos Diagnostics Holdings Limited (LDXHF) operate in?

Lumos Diagnostics Holdings Limited belongs to the Healthcare sector and operates in the Medical Devices industry.

What is Lumos Diagnostics Holdings Limited (LDXHF) current stock price?

As of the latest data, Lumos Diagnostics Holdings Limited stock price is $0.06, with a previous close of $0.06.

What is Lumos Diagnostics Holdings Limited (LDXHF) current market capitalization?

Lumos Diagnostics Holdings Limited market cap is approximately 57.81 million.

What is Lumos Diagnostics Holdings Limited (LDXHF) Earnings Per Share (EPS)?

The trailing EPS is -$0.01.

What is Lumos Diagnostics Holdings Limited (LDXHF) EBITDA?

Lumos Diagnostics Holdings Limited EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -6.54 million.

Does Lumos Diagnostics Holdings Limited (LDXHF) pay dividends?

No. Lumos Diagnostics Holdings Limited does not pay a dividend.

What is Lumos Diagnostics Holdings Limited (LDXHF) beta (volatility) score?

Lumos Diagnostics Holdings Limited has a beta of 0.462, indicating lower volatility than the overall market.